Dapagliflozin in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Sodium-glucose cotransporter-2 (SGLT2) inhibitors represent newly developed oral antidiabetic drugs that are practiced for type 2 diabetes mellitus management and may decrease the risk of the first hospitalization in heart failure. The activity of SGLT2 inhibitors is not related to glucose, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ru-ping, Xu, Yu-li, Su, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026320/
https://www.ncbi.nlm.nih.gov/pubmed/33859839
http://dx.doi.org/10.1155/2021/6657380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026320/
https://www.ncbi.nlm.nih.gov/pubmed/33859839
http://dx.doi.org/10.1155/2021/6657380

Ejemplares similares